Fibroblast growth factor-23 (FGF)-23 is a phosphaturic hormone involved in mineral bone
metabolism that helps control phosphate homeostasis and reduces 1, 25-dihydroxyvitamin …

Among all the biological entities involved in the immune response, galectins, a family of
glycan-binding proteins, have been described as key in immune cell homeostasis and …

Metabolic syndrome (MetS) is a complex metabolic disorder with a global prevalence of
20%–25%. Early identification and intervention would help minimize the global burden on …

Aims Recent evidence points towards a distinct obese phenotype among patients with heart
failure with preserved ejection fraction (HFpEF). We aimed to identify differentially expressed …

There is increasing evidence that HFpEF is a heterogeneous clinical entity and distinct
molecular pathways may contribute to pathophysiology. Leveraging unbiased proteomics to …

Cardiometabolic diseases, such as type 2 diabetes and cardiovascular disease, have a high
public health burden. Understanding the genetically determined regulation of proteins that …

Aim To determine the clinical correlates of increased red blood cell distribution width (RDW),
its potential mechanistic association with multiple circulating biomarkers, and its prognostic …

Aim To investigate the ability of the Thrombolysis in Myocardial Infarction Risk Score for
Heart Failure in Diabetes (TRS‐HFDM) to stratify patients with type 2 diabetes mellitus …

Diabetes and heart failure, as important global issues, cause substantial expenses to
countries and medical systems because of the morbidity and mortality rates. Most people …

Background Coronary heart disease (CHD) is a major global health concern, especially
among individuals with type 2 diabetes (T2D). Given the crucial role of proteins in various …